News

InTB Winners Announced!

Inaugural entrants showcase successful new approaches

Thank you to all who submitted entries to the first InnovateTB contest. We are delighted to be able to help promote them as an ongoing effort of the InnovateTB Library.

At the request of our stakeholders, we divided the winners into three categories: Overall Winner, Advocacy Winner (both selected from the popular vote getters by the expert panel), and Fan Favorite (most popular vote getter). We are proud to announce the 2012 InTB Award winners as follows:

Overall Winner

Advocacy Winner

Fan Favorite

ACTION: New technology saves lives

Delft Youth Theatre

The Electronic TB Register

Runner Up

Runner Up

Runner Up

A New Hope for Tuberculosis (MM4TB)

Stop TB’s Challenge Facility for Civil Society

Signature Mapping TBDx

Winners were determined by a combination of popular votes and review by our expert panel members. We would like to thank the panel for their time and guidance:

  • Veronique Dartois — Assistant Professor, Public Health Research Institute, UMDNJ
  • Lucica Ditiu — Executive Secretary, Stop TB Partnership
  • Ken Duncan — Deputy Director, Bill and Melinda Gates Foundation
  • Shobha Shukla — Editor and Director Diabetes Media Initiative, Citizen New Service

Beyond the scope of this contest, InTB aims to catalog and promote groundbreaking work in TB diagnosis, control, and treatment. We invite you to continue to submit innovations to our ongoing library — videos, photos or written accounts for TB innovations you have been involved in.

We look forward to seeing more TB Innovations!

More News
22 Jul 2024
The National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) has issued a $30.8 million grant to the Preclinical Design and Clinical Translation of TB Regimens (PreDiCTR) consortium , a new consortium co-led by investigators from Weill Cornell Medicine; the...
27 Jun 2024
On May 17, the World Health Organization (WHO) released its updated  Bacterial Priority Pathogens List (BPPL) 2024 and for the first time in its history it included a drug resistant strain of Mycobacterium tuberculosis. Along with three other new families of antibiotic-resistant bacterial pathogens...
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...